ReviewFrontiers in immunology2026

Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression.

Gonçalo Trindade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.